Popular Diabetes Drug May Lower Prostate Cancer Risk, Harvard School of Public Health Study

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Melatonin is a hormone that is produced exclusively at night in the dark and is an important output of the circadian rhythm, or the body’s inherent 24-hour clock.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC